Roland Rott, CEO of GE Healthcare Imaging on AI

In this episode of The CEO Interview, David Meier and Asit Sharma interview Roland Rott, CEO of GE Healthcare Imaging, about GE Healthcare's business model, its mission, and its use of AI. Roland discusses GE Healthcare's evolution into an independent public company after 123 years as part of General Electric, highlighting its $19.6 billion in revenues and impact on over a billion patients worldwide. He explains the company's D3 strategy—smart devices, smart drugs, and digital solutions—aimed at early disease detection, diagnosis, and treatment support, with a focus on areas like cancer and cardiovascular disease. The conversation covers major product areas such as X-ray, CT, MRI, and molecular imaging, with emphasis on the growth potential of molecular imaging and advanced therapies. Roland also details GE Healthcare's significant investment in R&D, particularly in AI, to enhance efficiency, improve image quality, and streamline processes, viewing AI as a co-pilot for physicians to improve patient outcomes.